Biotechnology
The Biotechnology industry has a total of 593 stocks, with a combined market cap of $1.22 trillion and total revenue of $116.52 billion.
Market Cap
1.22T
Revenue
116.52B
Profits
-35.51B
PE Ratio
n/a
Profit Margin
-30.48%
Dividend Yield
0.04%
593 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | VRTX | Vertex Pharmaceuticals Incorporated | 126.66B | -1.77% | 1,409,295 | 12.59B |
| 2 | MRNA | Moderna, Inc. | 87.04B | -7.82% | 21,386,437 | 2.23B |
| 3 | REGN | Regeneron Pharmaceuticals, Inc. | 78.96B | -0.70% | 653,853 | 15.53B |
| 4 | ARGX | argenx SE | 51.45B | -3.21% | 388,973 | 5.32B |
| 5 | ONC | BeOne Medicines AG | 41.96B | -1.34% | 422,234 | 6.13B |
| 6 | RVMD | Revolution Medicines, Inc. | 38.14B | -5.97% | 2,973,185 | - |
| 7 | RPRX | Royalty Pharma plc | 35.05B | 2.25% | 5,786,281 | 2.54B |
| 8 | ALNY | Alnylam Pharmaceuticals, Inc. | 31.02B | -0.94% | 1,404,750 | 4.80B |
| 9 | ROIV | Roivant Sciences Ltd. | 24.22B | -1.50% | 4,923,420 | 7.53M |
| 10 | INCY | Incyte Corporation | 22.92B | -0.18% | 1,580,704 | 5.82B |
| 11 | BNTX | BioNTech SE | 22.03B | -2.76% | 1,104,150 | 3.03B |
| 12 | GMAB | Genmab A/S | 22.01B | -2.17% | 1,906,891 | 4.13B |
| 13 | INSM | Insmed Incorporated | 21.02B | -2.96% | 2,395,740 | 1.14B |
| 14 | EXEL | Exelixis, Inc. | 15.42B | -0.95% | 2,637,178 | 2.44B |
| 15 | ASND | Ascendis Pharma A/S | 14.79B | -0.61% | 680,312 | 1.20B |
| 16 | HALO | Halozyme Therapeutics, Inc. | 13.83B | 0.27% | 2,081,608 | 1.66B |
| 17 | JAZZ | Jazz Pharmaceuticals plc | 13.65B | -1.95% | 636,698 | 4.60B |
| 18 | BBIO | BridgeBio Pharma, Inc. | 12.98B | -1.10% | 2,055,506 | 713.07M |
| 19 | CORT | Corcept Therapeutics Incorporated | 11.91B | -2.83% | 849,626 | 830.81M |
| 20 | SMMT | Summit Therapeutics Inc. | 11.70B | -4.81% | 4,313,704 | - |
| 21 | TECH | Bio-Techne Corporation | 11.38B | 0.07% | 2,646,860 | 1.22B |
| 22 | BMRN | BioMarin Pharmaceutical Inc. | 10.58B | -2.44% | 1,961,464 | 3.41B |
| 23 | MDGL | Madrigal Pharmaceuticals, Inc. | 10.39B | -2.19% | 281,308 | 1.28B |
| 24 | PCVX | Vaxcyte, Inc. | 10.01B | -2.53% | 3,374,505 | - |
| 25 | IBRX | ImmunityBio, Inc. | 9.73B | -8.20% | 21,439,645 | 165.79M |
| 26 | KRYS | Krystal Biotech, Inc. | 9.37B | -4.07% | 226,220 | 440.48M |
| 27 | KYMR | Kymera Therapeutics, Inc. | 8.71B | -3.11% | 488,723 | 105.00M |
| 28 | CAI | Caris Life Sciences, Inc. | 8.64B | -3.78% | 2,730,079 | 989.61M |
| 29 | CYTK | Cytokinetics, Incorporated | 8.61B | -3.08% | 861,664 | 67.67M |
| 30 | PTGX | Protagonist Therapeutics, Inc. | 8.33B | -5.71% | 886,732 | 281.99M |
| 31 | TWST | Twist Bioscience Corporation | 8.32B | -8.13% | 2,826,506 | 431.80M |
| 32 | AXSM | Axsome Therapeutics, Inc. | 8.23B | -2.87% | 873,076 | 776.57M |
| 33 | ARWR | Arrowhead Pharmaceuticals, Inc. | 7.90B | -4.44% | 1,772,713 | 669.50M |
| 34 | TGTX | TG Therapeutics, Inc. | 7.66B | -3.63% | 1,770,037 | 799.54M |
| 35 | SYRE | Spyre Therapeutics, Inc. | 7.47B | -0.25% | 1,273,321 | - |
| 36 | ABVX | ABIVAX Société Anonyme | 7.39B | -4.60% | 1,297,267 | 5.33M |
| 37 | IONS | Ionis Pharmaceuticals, Inc. | 7.14B | -2.67% | 1,674,763 | 874.09M |
| 38 | PRAX | Praxis Precision Medicines, Inc. | 6.75B | -2.61% | 502,560 | 7.46M |
| 39 | IOVA | Iovance Biotherapeutics, Inc. | 6.17B | -7.47% | 11,007,991 | 324.97M |
| 40 | RYTM | Rhythm Pharmaceuticals, Inc. | 5.93B | -2.05% | 364,054 | 239.92M |
| 41 | LGND | Ligand Pharmaceuticals Incorporated | 5.89B | -0.99% | 164,498 | 290.54M |
| 42 | BLTE | Belite Bio, Inc | 5.76B | -6.31% | 177,231 | - |
| 43 | IMVT | Immunovant, Inc. | 5.52B | -2.84% | 1,462,996 | - |
| 44 | KOD | Kodiak Sciences Inc. | 5.38B | -2.69% | 1,122,131 | - |
| 45 | CGON | CG Oncology, Inc. | 5.31B | -3.23% | 1,079,665 | 6.23M |
| 46 | MIRM | Mirum Pharmaceuticals, Inc. | 5.21B | -2.68% | 462,923 | 618.07M |
| 47 | COGT | Cogent Biosciences, Inc. | 5.12B | 0.03% | 2,782,712 | - |
| 48 | PTCT | PTC Therapeutics, Inc. | 4.94B | -2.87% | 787,545 | 1.01B |
| 49 | SRRK | Scholar Rock Holding Corporation | 4.86B | -1.82% | 2,893,997 | - |
| 50 | ORKA | Oruka Therapeutics, Inc. | 4.76B | -2.63% | 1,179,559 | - |
| 51 | CRSP | CRISPR Therapeutics AG | 4.76B | -4.41% | 1,517,474 | 13.39M |
| 52 | ERAS | Erasca, Inc. | 4.68B | -9.95% | 7,089,142 | - |
| 53 | TVTX | Travere Therapeutics, Inc. | 4.68B | -6.04% | 1,827,880 | 591.33M |
| 54 | MANE | Veradermics, Incorporated | 4.55B | -5.43% | 670,498 | - |
| 55 | DFTX | Definium Therapeutics, Inc. | 4.31B | -6.30% | 1,933,980 | - |
| 56 | EWTX | Edgewise Therapeutics, Inc. | 4.04B | -2.64% | 1,143,648 | - |
| 57 | DNTH | Dianthus Therapeutics, Inc. | 4.03B | -3.27% | 1,053,338 | 1.90M |
| 58 | ABCL | AbCellera Biologics Inc. | 3.82B | -6.94% | 4,098,331 | 66.17M |
| 59 | TLX | Telix Pharmaceuticals Limited | 3.76B | 1.14% | 324,831 | 890.79M |
| 60 | TNGX | Tango Therapeutics, Inc. | 3.72B | -2.91% | 3,688,261 | 53.81M |
| 61 | ARQT | Arcutis Biotherapeutics, Inc. | 3.62B | -0.89% | 1,731,947 | 463.98M |
| 62 | LEGN | Legend Biotech Corporation | 3.58B | -6.67% | 2,961,555 | 1.27B |
| 63 | RLAY | Relay Therapeutics, Inc. | 3.57B | -5.90% | 2,366,610 | 10.35M |
| 64 | ACAD | Acadia Pharmaceuticals Inc. | 3.29B | -2.99% | 1,672,142 | 1.14B |
| 65 | XENE | Xenon Pharmaceuticals Inc. | 3.24B | -2.45% | 1,070,669 | 7.50M |
| 66 | IDYA | IDEAYA Biosciences, Inc. | 3.17B | -2.95% | 655,113 | 234.13M |
| 67 | TARS | Tarsus Pharmaceuticals, Inc. | 2.99B | -4.11% | 2,432,245 | 606.33M |
| 68 | VKTX | Viking Therapeutics, Inc. | 2.94B | -8.04% | 7,564,473 | - |
| 69 | RCUS | Arcus Biosciences, Inc. | 2.82B | -3.07% | 1,425,531 | 117.00M |
| 70 | DNLI | Denali Therapeutics Inc. | 2.81B | -3.98% | 2,303,218 | 3.60M |
| 71 | PBLS | Parabilis Medicines, Inc. | 2.81B | -9.65% | 1,115,052 | 148.00K |
| 72 | CELC | Celcuity Inc. | 2.77B | -6.17% | 4,338,271 | - |
| 73 | ELVN | Enliven Therapeutics, Inc. | 2.73B | -5.11% | 1,188,419 | - |
| 74 | NRIX | Nurix Therapeutics, Inc. | 2.67B | -2.12% | 3,692,151 | 701.94M |
| 75 | DYN | Dyne Therapeutics, Inc. | 2.66B | -6.80% | 2,860,368 | - |
| 76 | ZLAB | Zai Lab Limited | 2.60B | -1.49% | 843,206 | 449.61M |
| 77 | ADMA | ADMA Biologics, Inc. | 2.39B | -0.47% | 3,073,662 | 512.28M |
| 78 | MBX | MBX Biosciences, Inc. | 2.39B | -2.13% | 818,907 | - |
| 79 | NAMS | NewAmsterdam Pharma Company N.V. | 2.37B | -3.83% | 1,937,147 | 7.12M |
| 80 | BEAM | Beam Therapeutics Inc. | 2.35B | -5.10% | 1,645,093 | 156.04M |
| 81 | PGEN | Precigen, Inc. | 2.29B | -11.26% | 5,477,157 | 85.72M |
| 82 | HRMY | Harmony Biosciences Holdings, Inc. | 2.21B | -0.76% | 892,251 | 959.90M |
| 83 | AUPH | Aurinia Pharmaceuticals Inc. | 2.20B | -1.20% | 736,075 | 311.51M |
| 84 | IRON | Disc Medicine, Inc. | 2.18B | 0.34% | 560,577 | - |
| 85 | CLDX | Celldex Therapeutics, Inc. | 2.16B | -4.84% | 997,946 | 158.00K |
| 86 | VRDN | Viridian Therapeutics, Inc. | 2.16B | -2.71% | 2,457,260 | 71.13M |
| 87 | FTRE | Fortrea Holdings Inc. | 2.14B | -1.12% | 1,837,670 | 2.68B |
| 88 | RXRX | Recursion Pharmaceuticals, Inc. | 2.07B | -16.71% | 40,553,689 | 54.86M |
| 89 | VCEL | Vericel Corporation | 2.05B | -2.17% | 737,126 | 306.30M |
| 90 | SLS | SELLAS Life Sciences Group, Inc. | 2.02B | -11.99% | 15,760,582 | - |
| 91 | VERA | Vera Therapeutics, Inc. | 2.01B | -2.42% | 1,294,215 | - |
| 92 | ADRX | ADARx Pharmaceuticals, Inc. | 1.98B | -0.28% | 247,128 | 6.13M |
| 93 | PHVS | Pharvaris N.V. | 1.95B | -6.41% | 1,307,613 | - |
| 94 | LKFT | Lakefront Biotherapeutics NV | 1.90B | 0.10% | 250,892 | 1.13B |
| 95 | IMNM | Immunome, Inc. | 1.87B | -5.34% | 1,296,636 | 4.02M |
| 96 | AGIO | Agios Pharmaceuticals, Inc. | 1.87B | -3.09% | 952,660 | 98.34M |
| 97 | NVAX | Novavax, Inc. | 1.86B | -12.17% | 9,338,398 | 413.80M |
| 98 | SRPT | Sarepta Therapeutics, Inc. | 1.81B | -3.88% | 9,855,870 | 1.97B |
| 99 | MESO | Mesoblast Limited | 1.80B | -4.80% | 615,686 | 120.25M |
| 100 | MLYS | Mineralys Therapeutics, Inc. | 1.79B | -6.19% | 1,181,193 | - |
| 101 | ZYME | Zymeworks Inc. | 1.78B | -2.80% | 631,860 | 37.13M |
| 102 | MRVI | Maravai LifeSciences Holdings, Inc. | 1.76B | -3.96% | 2,215,098 | 208.78M |
| 103 | PVLA | Palvella Therapeutics, Inc. | 1.73B | -5.53% | 179,489 | - |
| 104 | XNCR | Xencor, Inc. | 1.70B | -4.79% | 1,129,943 | 104.97M |
| 105 | SEPN | Septerna, Inc. | 1.70B | -2.94% | 234,122 | 98.88M |
| 106 | TRVI | Trevi Therapeutics, Inc. | 1.69B | -1.90% | 2,704,402 | - |
| 107 | URGN | UroGen Pharma Ltd. | 1.69B | -5.60% | 1,046,260 | 188.73M |
| 108 | VIR | Vir Biotechnology, Inc. | 1.69B | -4.87% | 1,735,243 | 303.23M |
| 109 | BHVN | Biohaven Ltd. | 1.63B | -5.69% | 1,843,698 | - |
| 110 | ZBIO | Zenas BioPharma, Inc. | 1.62B | -2.20% | 661,703 | 1.00M |
| 111 | NTLA | Intellia Therapeutics, Inc. | 1.60B | 0.71% | 8,219,716 | 59.51M |
| 112 | NUVB | Nuvation Bio Inc. | 1.56B | -6.32% | 4,470,400 | 169.90M |
| 113 | STOK | Stoke Therapeutics, Inc. | 1.56B | -1.79% | 880,121 | 27.59M |
| 114 | GENB | Generate Biomedicines, Inc. | 1.55B | -7.43% | 1,074,650 | 26.48M |
| 115 | MAZE | Maze Therapeutics, Inc. | 1.53B | 0.18% | 1,018,474 | 20.00M |
| 116 | IMCR | Immunocore Holdings plc | 1.51B | -0.27% | 924,921 | 430.78M |
| 117 | QURE | uniQure N.V. | 1.51B | -3.29% | 1,292,840 | 18.67M |
| 118 | BRVE | Braveheart Bio, Inc. | 1.51B | -5.42% | 414,852 | - |
| 119 | OCUL | Ocular Therapeutix, Inc. | 1.51B | -6.91% | 2,761,251 | 52.06M |
| 120 | GPCR | Structure Therapeutics Inc. | 1.50B | -5.00% | 1,160,591 | - |
| 121 | INVA | Innoviva, Inc. | 1.50B | -0.38% | 550,474 | 440.00M |
| 122 | KRSA | Korsana Biosciences, Inc. | 1.49B | -3.02% | 112,916 | - |
| 123 | KLRA | Kailera Therapeutics, Inc. | 1.46B | -3.93% | 1,299,332 | - |
| 124 | AAPG | Ascentage Pharma Group International | 1.46B | 4.63% | 15,091 | 94.61M |
| 125 | RARE | Ultragenyx Pharmaceutical Inc. | 1.43B | -4.15% | 2,924,015 | 717.00M |
| 126 | ABSI | Absci Corporation | 1.42B | -7.09% | 2,929,554 | 1.56M |
| 127 | COAG | Hemab Therapeutics Holdings, Inc. | 1.40B | -7.66% | 351,756 | - |
| 128 | ANAB | AnaptysBio, Inc. | 1.39B | -4.31% | 413,631 | 106.09M |
| 129 | RAPP | Rapport Therapeutics, Inc. | 1.32B | -6.76% | 412,062 | 20.00M |
| 130 | INBX | Inhibrx Biosciences, Inc. | 1.32B | -0.74% | 145,953 | 1.30M |
| 131 | ORIC | ORIC Pharmaceuticals, Inc. | 1.28B | -3.29% | 723,880 | - |
| 132 | TYRA | Tyra Biosciences, Inc. | 1.27B | -2.73% | 648,944 | - |
| 133 | GHRS | GH Research PLC | 1.25B | -3.46% | 162,602 | - |
| 134 | TRAX | First Tracks Biotherapeutics, Inc. | 1.23B | -4.38% | 1,041,417 | - |
| 135 | NKTR | Nektar Therapeutics | 1.22B | -5.14% | 784,232 | 54.59M |
| 136 | KARD | Kardigan, Inc. | 1.22B | -6.20% | 717,612 | - |
| 137 | LBRX | LB Pharmaceuticals Inc | 1.19B | 0.14% | 724,736 | - |
| 138 | TSHA | Taysha Gene Therapies, Inc. | 1.18B | -2.95% | 2,751,375 | 5.49M |
| 139 | OMER | Omeros Corporation | 1.17B | -13.78% | 3,962,367 | 38.42M |
| 140 | SNDX | Syndax Pharmaceuticals, Inc. | 1.15B | -5.49% | 2,837,588 | 252.25M |
| 141 | DMRA | Damora Therapeutics, Inc. | 1.14B | -1.60% | 836,705 | - |
| 142 | DRTS | Alpha Tau Medical Ltd. | 1.13B | -6.61% | 778,734 | - |
| 143 | SVRA | Savara Inc. | 1.13B | -6.12% | 2,232,230 | - |
| 144 | IAM | Iambic Therapeutics, Inc. | 1.13B | 25.91% | 2,679,252 | 18.25M |
| 145 | BCAX | Bicara Therapeutics Inc. | 1.11B | -4.77% | 819,996 | - |
| 146 | CTY | City Therapeutics, Inc. | 1.08B | -10.58% | 1,345,648 | 14.34M |
| 147 | VOR | Vor Biopharma Inc. | 1.07B | -6.77% | 733,077 | - |
| 148 | VSTM | Verastem, Inc. | 1.05B | -6.28% | 6,087,645 | 87.53M |
| 149 | AVLN | Avalyn Pharma Inc. | 1.05B | -3.98% | 291,431 | - |
| 150 | NBTX | Nanobiotix S.A. | 1.05B | -4.18% | 77,771 | 13.15M |
| 151 | REPL | Replimune Group, Inc. | 1.02B | -7.57% | 1,710,753 | - |
| 152 | JANX | Janux Therapeutics, Inc. | 1.01B | -4.68% | 765,883 | 24.00M |
| 153 | MNKD | MannKind Corporation | 977.48M | -4.70% | 2,604,463 | 393.63M |
| 154 | SPTX | Seaport Therapeutics, Inc. | 954.45M | 1.31% | 184,538 | - |
| 155 | LTGO | Latigo Biotherapeutics, Inc. | 928.19M | -5.15% | 207,358 | - |
| 156 | IMTX | Immatics N.V. | 919.92M | -5.74% | 1,154,876 | 47.65M |
| 157 | MGTX | MeiraGTx Holdings plc | 891.28M | -6.17% | 666,426 | 397.50M |
| 158 | SLBT | SL Science Holding Limited | 869.66M | -1.61% | 24,821 | 3.27M |
| 159 | ANRO | Alto Neuroscience, Inc. | 860.97M | -3.01% | 520,885 | - |
| 160 | RIGL | Rigel Pharmaceuticals, Inc. | 858.34M | -2.75% | 141,429 | 276.79M |
| 161 | JBIO | Jade Biosciences, Inc. | 856.66M | -2.11% | 980,976 | - |
| 162 | AKTS | Aktis Oncology, Inc. | 837.63M | -5.93% | 394,795 | 10.06M |
| 163 | ABUS | Arbutus Biopharma Corporation | 834.92M | -1.63% | 4,541,643 | 181.72M |
| 164 | GLUE | Monte Rosa Therapeutics, Inc. | 830.95M | -3.75% | 883,187 | 28.73M |
| 165 | CGEM | Cullinan Therapeutics, Inc. | 830.82M | -7.79% | 1,123,252 | - |
| 166 | ODTX | Odyssey Therapeutics, Inc. | 822.76M | -2.28% | 162,483 | 99.00K |
| 167 | AVBP | ArriVent BioPharma, Inc. | 821.47M | -0.77% | 1,334,017 | - |
| 168 | MLTX | MoonLake Immunotherapeutics | 812.77M | -6.92% | 1,380,680 | - |
| 169 | KURA | Kura Oncology, Inc. | 807.76M | -6.39% | 1,423,286 | 77.23M |
| 170 | SGP | SpyGlass Pharma, Inc. | 802.75M | -2.91% | 70,647 | - |
| 171 | CRVS | Corvus Pharmaceuticals, Inc. | 801.67M | -3.25% | 1,035,515 | - |
| 172 | ALMS | Alumis Inc. | 792.14M | -3.01% | 2,496,311 | 7.40M |
| 173 | HELP | Helus Pharma Inc. | 770.78M | -4.52% | 1,310,214 | - |
| 174 | ARDX | Ardelyx, Inc. | 769.99M | -5.50% | 5,775,542 | 450.89M |
| 175 | GERN | Geron Corporation | 751.69M | -4.88% | 3,239,016 | 204.56M |
| 176 | APMD | Apnimed, Inc. | 739.36M | -2.66% | 235,053 | 115.12M |
| 177 | OBX | Obsidian Therapeutics, Inc. | 727.07M | -3.52% | 297,675 | - |
| 178 | ANL | Adlai Nortye Group Ltd. | 710.31M | -8.77% | 336,584 | 18.06M |
| 179 | IVA | Inventiva S.A. | 709.43M | -5.47% | 4,852,207 | 2.81M |
| 180 | DNA | Ginkgo Bioworks Holdings, Inc. | 691.58M | -12.67% | 3,549,830 | 132.42M |
| 181 | SANA | Sana Biotechnology, Inc. | 679.55M | -8.28% | 3,088,227 | - |
| 182 | LXRX | Lexicon Pharmaceuticals, Inc. | 676.33M | -7.88% | 2,007,632 | 41.47M |
| 183 | FDMT | 4D Molecular Therapeutics, Inc. | 671.77M | -5.52% | 794,526 | 92.01M |
| 184 | OABI | OmniAb, Inc. | 667.34M | -2.96% | 969,406 | 38.46M |
| 185 | IMMX | Immix Biopharma, Inc. | 661.57M | -8.06% | 1,503,765 | - |
| 186 | ACHV | Achieve Life Sciences, Inc. | 656.52M | -8.46% | 1,990,372 | - |
| 187 | PHAR | Pharming Group N.V. | 648.54M | -2.80% | 9,028 | 366.48M |
| 188 | ANNX | Annexon, Inc. | 648.36M | -5.00% | 5,240,022 | - |
| 189 | MDXG | MiMedx Group, Inc. | 645.72M | -5.34% | 2,728,255 | 355.17M |
| 190 | DSGN | Design Therapeutics, Inc. | 645.22M | -1.62% | 854,547 | - |
| 191 | GYRE | Gyre Therapeutics, Inc. | 644.69M | -5.00% | 142,874 | 109.82M |
| 192 | AURA | Aura Biosciences, Inc. | 632.60M | -3.79% | 762,443 | - |
| 193 | ATTO | Attovia Therapeutics, Inc. | 626.79M | -7.10% | 871,766 | 1.80M |
| 194 | CADL | Candel Therapeutics, Inc. | 626.69M | -8.08% | 1,339,088 | - |
| 195 | PRME | Prime Medicine, Inc. | 617.33M | -3.88% | 4,383,228 | 4.07M |
| 196 | WVE | Wave Life Sciences, Inc. | 616.76M | -1.88% | 3,281,706 | 65.37M |
| 197 | NVCT | Nuvectis Pharma, Inc. | 607.65M | -1.48% | 158,421 | - |
| 198 | AVTX | Avalo Therapeutics, Inc. | 604.41M | -6.16% | 971,072 | 59.00K |
| 199 | SLDB | Solid Biosciences Inc. | 592.96M | -3.66% | 1,401,827 | - |
| 200 | ZVRA | Zevra Therapeutics, Inc. | 590.27M | -3.21% | 593,878 | 136.07M |
| 201 | OLMA | Olema Pharmaceuticals, Inc. | 575.73M | -4.22% | 1,081,293 | - |
| 202 | SGMT | Sagimet Biosciences Inc. | 568.69M | -1.84% | 1,088,857 | - |
| 203 | CRMD | CorMedix Inc. | 565.88M | -2.68% | 1,140,448 | 462.25M |
| 204 | CLYM | Climb Bio, Inc. | 564.02M | -9.99% | 990,343 | - |
| 205 | PHAT | Phathom Pharmaceuticals, Inc. | 549.66M | -7.73% | 1,254,048 | 239.66M |
| 206 | ETRA | Electra Therapeutics, Inc. | 549.21M | - | 1,380,472 | - |
| 207 | STTK | Shattuck Labs, Inc. | 543.97M | -1.99% | 648,464 | 1.00M |
| 208 | SLN | Silence Therapeutics plc | 522.02M | -7.27% | 1,131,128 | 615.00K |
| 209 | DBVT | DBV Technologies S.A. | 521.99M | -0.66% | 592,916 | 5.04M |
| 210 | VALN | Valneva SE | 521.34M | -5.08% | 9,483 | 163.30M |
| 211 | DRUG | Bright Minds Biosciences Inc. | 512.25M | -4.81% | 50,706 | - |
| 212 | PBYI | Puma Biotechnology, Inc. | 506.91M | -6.65% | 406,589 | 231.24M |
| 213 | CBIO | Crescent Biopharma, Inc. | 506.76M | -5.13% | 208,141 | 11.88M |
| 214 | CTMX | CytomX Therapeutics, Inc. | 496.81M | -5.39% | 3,178,634 | 18.30M |
| 215 | FTH | Faeth Therapeutics, Inc. | 485.80M | -8.74% | 595,929 | - |
| 216 | ACRS | Aclaris Therapeutics, Inc. | 482.81M | -6.02% | 2,455,553 | 8.22M |
| 217 | ENTX | Entera Bio Ltd. | 466.11M | -3.25% | 572,831 | 42.00K |
| 218 | NGNE | Neurogene Inc. | 465.26M | -2.92% | 571,499 | 925.00K |
| 219 | MNPR | Monopar Therapeutics Inc. | 464.95M | -3.52% | 142,398 | - |
| 220 | RGNX | REGENXBIO Inc. | 457.14M | -3.28% | 1,209,626 | 174.48M |
| 221 | ARVN | Arvinas, Inc. | 455.74M | -2.65% | 759,130 | 316.70M |
| 222 | ALLO | Allogene Therapeutics, Inc. | 452.59M | -2.24% | 4,918,561 | 4.64M |
| 223 | OCS | Oculis Holding AG | 450.03M | -1.49% | 293,677 | 1.45M |
| 224 | BLSM | BlossomHill Therapeutics, Inc. | 443.08M | -6.94% | 293,107 | - |
| 225 | OVID | Ovid Therapeutics Inc. | 441.37M | -4.87% | 1,325,038 | 1.58M |
| 226 | EPRX | Eupraxia Pharmaceuticals Inc. | 437.14M | -2.22% | 582,306 | - |
| 227 | PRTA | Prothena Corporation plc | 429.05M | -1.68% | 670,248 | 54.53M |
| 228 | ALT | Altimmune, Inc. | 427.94M | -6.78% | 4,233,320 | 31.00K |
| 229 | MPLT | MapLight Therapeutics, Inc. | 427.93M | -3.99% | 359,057 | - |
| 230 | AUTL | Autolus Therapeutics plc | 425.86M | -6.98% | 2,300,702 | 117.39M |
| 231 | YDES | YD Bio Limited | 419.32M | -12.17% | 153,370 | 1.24M |
| 232 | ASMB | Assembly Biosciences, Inc. | 409.04M | -2.33% | 167,734 | 74.85M |
| 233 | DMAC | DiaMedica Therapeutics Inc. | 408.22M | -5.85% | 260,777 | - |
| 234 | AGMB | AgomAb Therapeutics NV | 407.77M | -0.60% | 78,132 | - |
| 235 | TECX | Tectonic Therapeutic, Inc. | 403.69M | -3.05% | 175,415 | - |
| 236 | PROK | ProKidney Corp. | 402.09M | -8.59% | 1,654,055 | 818.00K |
| 237 | EIKN | Eikon Therapeutics, Inc. | 401.90M | -1.59% | 482,732 | - |
| 238 | SPRY | ARS Pharmaceuticals, Inc. | 399.78M | -1.23% | 2,331,995 | 116.93M |
| 239 | CAPR | Capricor Therapeutics, Inc. | 390.11M | -7.70% | 1,920,126 | 11.13M |
| 240 | SCTX | Scribe Therapeutics Inc. | 380.15M | -3.09% | 201,393 | 33.30M |
| 241 | TRXB | TRex Bio, Inc. | 377.18M | -1.06% | 81,864 | - |
| 242 | RZLT | Rezolute, Inc. | 375.53M | -8.21% | 1,397,813 | - |
| 243 | ZURA | Zura Bio Limited | 371.82M | -9.35% | 4,881,409 | - |
| 244 | GALT | Galectin Therapeutics Inc. | 365.08M | -2.43% | 169,402 | - |
| 245 | EDIT | Editas Medicine, Inc. | 360.91M | -3.69% | 1,550,898 | 47.01M |
| 246 | KYTX | Kyverna Therapeutics, Inc. | 350.65M | -5.03% | 724,520 | - |
| 247 | INDP | Indaptus Therapeutics, Inc. | 350.43M | -7.72% | 496,163 | - |
| 248 | FENC | Fennec Pharmaceuticals Inc. | 349.97M | -3.57% | 129,970 | 59.22M |
| 249 | AVIR | Atea Pharmaceuticals, Inc. | 346.48M | -4.64% | 345,810 | - |
| 250 | CCCC | C4 Therapeutics, Inc. | 340.16M | -0.54% | 2,359,296 | 35.04M |
| 251 | PRLD | Prelude Therapeutics Incorporated | 333.70M | -2.41% | 479,270 | 22.42M |
| 252 | RLMD | Relmada Therapeutics, Inc. | 330.68M | -3.13% | 1,279,313 | - |
| 253 | VTVT | vTv Therapeutics Inc. | 328.57M | -4.15% | 11,805 | 36.84M |
| 254 | OBIO | Orchestra BioMed Holdings, Inc. | 327.57M | -5.05% | 473,575 | 31.98M |
| 255 | ENTA | Enanta Pharmaceuticals, Inc. | 323.87M | -3.05% | 215,412 | 65.26M |
| 256 | IRD | Opus Genetics, Inc. | 319.47M | -5.19% | 2,397,337 | 9.86M |
| 257 | TTRX | Turn Therapeutics Inc. | 315.75M | -8.54% | 105,614 | - |
| 258 | IKT | Inhibikase Therapeutics, Inc. | 300.42M | -9.84% | 917,212 | 1.00 |
| 259 | ARCT | Arcturus Therapeutics Holdings Inc. | 294.18M | -8.16% | 831,609 | 29.37M |
| 260 | ARTV | Artiva Biotherapeutics, Inc. | 286.50M | -3.30% | 573,143 | 251.00K |
| 261 | BNTC | Benitec Biopharma Inc. | 282.90M | -4.14% | 158,557 | - |
| 262 | FULC | Fulcrum Therapeutics, Inc. | 278.48M | -0.54% | 1,385,295 | 80.00M |
| 263 | SRZN | Surrozen, Inc. | 275.50M | -6.50% | 268,991 | 11.51M |
| 264 | AGEN | Agenus Inc. | 271.92M | -9.58% | 1,028,327 | 132.69M |
| 265 | CTNM | Contineum Therapeutics, Inc. | 266.36M | -10.38% | 1,107,322 | - |
| 266 | CUVL | Clinuvel Pharmaceuticals Limited | 265.26M | 3.46% | 3,235 | 65.05M |
| 267 | OCGN | Ocugen, Inc. | 264.61M | -4.10% | 4,429,622 | 4.58M |
| 268 | NAUT | Nautilus Biotechnology, Inc. | 262.15M | -4.63% | 6,413,643 | 190.00K |
| 269 | EYPT | EyePoint, Inc. | 257.77M | -4.78% | 2,750,525 | 2.79M |
| 270 | XFOR | X4 Pharmaceuticals, Inc. | 256.29M | -2.08% | 967,582 | 15.85M |
| 271 | ABEO | Abeona Therapeutics Inc. | 253.33M | -4.73% | 819,503 | 25.52M |
| 272 | VCRE | Vicore Pharma Holding AB (publ) | 248.67M | -1.21% | 3,090 | 412.09K |
| 273 | IPSC | Century Therapeutics, Inc. | 248.07M | -8.67% | 721,503 | 109.16M |
| 274 | LCTX | Lineage Cell Therapeutics, Inc. | 247.42M | -1.21% | 1,308,652 | 13.08M |
| 275 | PALI | Palisade Bio, Inc. | 245.72M | -8.44% | 3,887,801 | 500.00K |
| 276 | VNDA | Vanda Pharmaceuticals Inc. | 244.15M | -4.76% | 1,049,440 | 215.72M |
| 277 | BCYC | Bicycle Therapeutics plc | 242.18M | -3.89% | 565,531 | 61.21M |
| 278 | RCKT | Rocket Pharmaceuticals, Inc. | 239.31M | -7.63% | 1,966,675 | - |
| 279 | CABA | Cabaletta Bio, Inc. | 239.06M | -9.03% | 6,672,459 | - |
| 280 | ACIU | AC Immune SA | 237.63M | -2.45% | 126,849 | 21.67M |
| 281 | IMRX | Immuneering Corporation | 232.26M | -1.37% | 747,787 | - |
| 282 | SABS | SAB Biotherapeutics, Inc. | 230.20M | -2.32% | 756,767 | 114.70K |
| 283 | BBOT | BridgeBio Oncology Therapeutics, Inc. | 226.09M | -4.41% | 480,756 | - |
| 284 | QTTB | Q32 Bio Inc. | 223.87M | -3.22% | 677,990 | 53.74M |
| 285 | LXEO | Lexeo Therapeutics, Inc. | 216.59M | -4.35% | 2,506,681 | - |
| 286 | VOGX | Vogenx, Inc. | 215.84M | -9.47% | 83,894 | - |
| 287 | FATE | Fate Therapeutics, Inc. | 214.48M | -7.01% | 1,273,862 | 6.49M |
| 288 | GLSI | Greenwich LifeSciences, Inc. | 213.57M | -5.03% | 107,670 | - |
| 289 | KROS | Keros Therapeutics, Inc. | 211.36M | -3.96% | 169,636 | 15.01M |
| 290 | PLX | Protalix BioTherapeutics, Inc. | 211.10M | -2.96% | 1,184,747 | 80.62M |
| 291 | SLGL | Sol-Gel Technologies Ltd. | 210.35M | -6.48% | 69,820 | 1.80M |
| 292 | LRMR | Larimar Therapeutics, Inc. | 208.77M | 0.50% | 1,691,961 | - |
| 293 | MGNX | MacroGenics, Inc. | 207.03M | -3.56% | 410,549 | 175.14M |
| 294 | ALEC | Alector, Inc. | 205.45M | -3.66% | 4,858,154 | 13.86M |
| 295 | ZNTL | Zentalis Pharmaceuticals, Inc. | 201.65M | -4.91% | 1,101,801 | 26.87M |
| 296 | PYXS | Pyxis Oncology, Inc. | 200.69M | -6.67% | 908,231 | 11.04M |
| 297 | LYEL | Lyell Immunopharma, Inc. | 199.72M | -0.49% | 194,964 | 27.00K |
| 298 | CAMP | Camp4 Therapeutics Corporation | 198.93M | -8.12% | 92,404 | 4.22M |
| 299 | IFRX | InflaRx N.V. | 194.53M | -8.33% | 1,535,081 | -11.54K |
| 300 | RNAC | Cartesian Therapeutics, Inc. | 189.40M | -4.86% | 112,729 | 1.48M |
| 301 | EVMN | Evommune, Inc. | 187.63M | -12.82% | 986,356 | 10.00M |
| 302 | CGEN | Compugen Ltd. | 185.66M | -5.77% | 169,433 | 74.00M |
| 303 | PRQR | ProQR Therapeutics N.V. | 184.87M | -9.66% | 1,061,101 | 21.05M |
| 304 | IVVD | Invivyd, Inc. | 182.34M | -7.51% | 3,442,637 | 58.37M |
| 305 | STRO | Sutro Biopharma, Inc. | 181.40M | -4.54% | 363,464 | 45.70M |
| 306 | PEPG | PepGen Inc. | 180.07M | 2.77% | 1,199,348 | - |
| 307 | ACOG | Alpha Cognition Inc. | 178.36M | -3.08% | 70,408 | 15.26M |
| 308 | SION | Sionna Therapeutics, Inc. | 175.88M | -4.66% | 1,483,448 | - |
| 309 | ELDN | Eledon Pharmaceuticals, Inc. | 173.26M | -6.17% | 783,580 | - |
| 310 | NGEN | NervGen Pharma Corp. | 170.96M | -1.85% | 387,776 | - |
| 311 | YARW | Yarrow Bioscience, Inc. | 169.62M | -8.85% | 60,926 | - |
| 312 | ORMP | Oramed Pharmaceuticals Inc. | 169.30M | -2.63% | 277,084 | 2.00M |
| 313 | WHWK | Whitehawk Therapeutics, Inc. | 164.76M | -4.93% | 273,975 | 7.15M |
| 314 | DTIL | Precision BioSciences, Inc. | 159.26M | -6.48% | 300,247 | 45.06M |
| 315 | TRDA | Entrada Therapeutics, Inc. | 157.57M | -8.58% | 371,791 | 4.69M |
| 316 | VRXA | Veraxa Biotech AG | 156.96M | 0.91% | 125,381 | 29.54K |
| 317 | CMPX | Compass Therapeutics, Inc. | 154.88M | -4.09% | 1,504,628 | 850.00K |
| 318 | MDWD | MediWound Ltd. | 153.25M | -2.78% | 33,443 | 11.86M |
| 319 | CHRS | Coherus Oncology, Inc. | 152.96M | -7.48% | 938,494 | 50.94M |
| 320 | UPB | Upstream Bio, Inc. | 151.17M | -18.10% | 1,704,697 | 3.16M |
| 321 | ALXO | ALX Oncology Holdings Inc. | 146.57M | 6.00% | 2,202,405 | - |
| 322 | NBP | NovaBridge Biosciences | 146.16M | -2.33% | 350,685 | - |
| 323 | MOLN | Molecular Partners AG | 144.13M | -2.47% | 678 | 856.30K |
| 324 | ADAG | Adagene Inc. | 138.32M | -14.17% | 379,601 | 9.29M |
| 325 | MSLE | Satellos Bioscience Inc. | 138.18M | -5.56% | 13,320 | - |
| 326 | TARA | Protara Therapeutics, Inc. | 137.10M | -3.33% | 1,054,086 | - |
| 327 | MENS | Jyong Biotech Ltd. | 136.59M | -7.07% | 41,171 | - |
| 328 | CDXS | Codexis, Inc. | 135.79M | -8.82% | 895,495 | 77.68M |
| 329 | TLSA | Tiziana Life Sciences Ltd | 135.77M | - | 558,773 | - |
| 330 | CNTN | Canton Strategic Holdings, Inc. | 135.06M | -9.36% | 1,191,987 | 1.50M |
| 331 | IPHA | Innate Pharma S.A. | 132.61M | -3.38% | 7,857 | 11.21M |
| 332 | RNA | Atrium Therapeutics, Inc. | 131.37M | -1.79% | 190,974 | 35.84M |
| 333 | NKTX | Nkarta, Inc. | 128.92M | -6.74% | 1,751,036 | - |
| 334 | ANTX | AN2 Therapeutics, Inc. | 127.55M | -6.11% | 281,726 | - |
| 335 | ARMP | Armata Pharmaceuticals, Inc. | 125.30M | 9.06% | 154,309 | 5.54M |
| 336 | KRRO | Korro Bio, Inc. | 125.02M | -8.81% | 129,226 | 2.38M |
| 337 | ABOS | Acumen Pharmaceuticals, Inc. | 122.22M | 1.20% | 449,337 | - |
| 338 | AVXL | Anavex Life Sciences Corp. | 121.43M | -11.49% | 1,469,934 | - |
| 339 | CUE | Cue Biopharma, Inc. | 121.39M | -10.50% | 105,191 | 37.66M |
| 340 | HUMA | Humacyte, Inc. | 119.18M | -2.39% | 5,960,812 | 2.12M |
| 341 | OTLK | Outlook Therapeutics, Inc. | 118.85M | -2.36% | 3,047,370 | -1.16M |
| 342 | RTSN | Retension Pharmaceuticals, Inc. | 117.23M | 15.23% | 208,879 | - |
| 343 | VYGR | Voyager Therapeutics, Inc. | 116.77M | -7.77% | 573,187 | 34.46M |
| 344 | SPRB | Spruce Biosciences, Inc. | 113.95M | -4.39% | 88,430 | 697.00K |
| 345 | NRXP | NRx Pharmaceuticals, Inc. | 112.48M | -4.06% | 1,210,191 | 3.39M |
| 346 | SEER | Seer, Inc. | 112.41M | -0.49% | 147,370 | 14.22M |
| 347 | NERV | Minerva Neurosciences, Inc. | 112.21M | -2.89% | 85,596 | - |
| 348 | HURA | TuHURA Biosciences, Inc. | 112.16M | -3.83% | 85,880 | - |
| 349 | ENGN | enGene Therapeutics Inc. | 111.58M | -2.63% | 1,156,472 | - |
| 350 | TVGN | Tevogen Inc. | 111.26M | -0.14% | 2,284 | - |
| 351 | FHTX | Foghorn Therapeutics Inc. | 110.46M | -1.59% | 981,234 | 36.74M |
| 352 | GNLX | Genelux Corporation | 108.45M | -2.42% | 277,868 | 8.00K |
| 353 | TNXP | Tonix Pharmaceuticals Holding Corp. | 103.59M | -5.92% | 889,035 | 29.10M |
| 354 | LENZ | LENZ Therapeutics, Inc. | 103.06M | -8.12% | 938,849 | 21.48M |
| 355 | INO | Inovio Pharmaceuticals, Inc. | 102.37M | -4.80% | 2,050,719 | 65.34K |
| 356 | VANI | Vivani Medical, Inc. | 101.03M | -2.61% | 361,575 | - |
| 357 | CBUS | Cibus, Inc. | 100.50M | 1.94% | 45,195 | 4.35M |
| 358 | COYA | Coya Therapeutics, Inc. | 99.70M | -2.07% | 134,190 | 8.02M |
| 359 | MIST | Milestone Pharmaceuticals Inc. | 99.67M | -10.98% | 974,358 | 2.34M |
| 360 | KZIA | Kazia Therapeutics Limited | 99.35M | -2.03% | 263,871 | 1.27M |
| 361 | BDTX | Black Diamond Therapeutics, Inc. | 98.82M | -1.15% | 539,751 | 70.00M |
| 362 | ICCC | ImmuCell Corporation | 97.63M | 1.80% | 2,900 | 30.68M |
| 363 | NRXS | NeurAxis, Inc. | 96.69M | -0.52% | 228,980 | 5.32M |
| 364 | PYPD | PolyPid Ltd. | 96.48M | -3.06% | 150,478 | - |
| 365 | IMUX | Immunic, Inc. | 95.10M | -1.83% | 366,215 | - |
| 366 | PLYX | Polaryx Therapeutics, Inc. | 93.71M | -3.59% | 19,479 | - |
| 367 | UNCY | Unicycive Therapeutics, Inc. | 93.59M | -6.41% | 1,014,020 | - |
| 368 | ANIX | Anixa Biosciences, Inc. | 92.82M | -3.96% | 123,305 | - |
| 369 | ATRA | Atara Biotherapeutics, Inc. | 92.15M | -4.87% | 19,493 | 6.19M |
| 370 | PMVP | PMV Pharmaceuticals, Inc. | 91.37M | -6.20% | 357,039 | - |
| 371 | RANI | Rani Therapeutics Holdings, Inc. | 89.30M | -5.79% | 589,120 | 4.88M |
| 372 | NMRA | Neumora Therapeutics, Inc. | 89.03M | 10.96% | 3,256,560 | - |
| 373 | CRBP | Corbus Pharmaceuticals Holdings, Inc. | 87.42M | 4.39% | 1,065,287 | - |
| 374 | RLYB | Rallybio Corporation | 86.45M | -2.95% | 36,431 | 646.00K |
| 375 | CNXU | Conexeu Sciences Inc. | 86.31M | -22.53% | 663,571 | - |
| 376 | TNYA | Tenaya Therapeutics, Inc. | 85.36M | -6.78% | 6,578,965 | 1.34M |
| 377 | OKUR | OnKure Therapeutics, Inc. | 85.04M | -1.41% | 386,004 | - |
| 378 | AARD | Aardvark Therapeutics, Inc. | 83.16M | -1.55% | 97,163 | - |
| 379 | PDSB | PDS Biotechnology Corporation | 81.90M | -13.08% | 6,879,055 | - |
| 380 | CLLS | Cellectis S.A. | 79.90M | -5.43% | 81,359 | 63.82M |
| 381 | TENX | Tenax Therapeutics, Inc. | 77.90M | -9.93% | 1,774,605 | - |
| 382 | TELO | Telomir Pharmaceuticals, Inc. | 77.30M | - | 34,481 | - |
| 383 | PTHS | Pelthos Therapeutics Inc. | 77.14M | -0.54% | 72,624 | 43.30M |
| 384 | NTRB | Nutriband Inc. | 75.61M | -0.80% | 27,918 | 1.62M |
| 385 | EQ | Equillium, Inc. | 75.46M | -9.85% | 466,785 | 4.39M |
| 386 | OKYO | OKYO Pharma Limited | 74.00M | -1.40% | 25,606 | - |
| 387 | PMN | ProMIS Neurosciences, Inc. | 73.09M | -6.32% | 20,407 | - |
| 388 | ACRV | Acrivon Therapeutics, Inc. | 70.28M | -6.82% | 261,578 | - |
| 389 | CRDF | Cardiff Oncology, Inc. | 70.10M | -7.20% | 515,538 | 508.00K |
| 390 | MNOV | MediciNova, Inc. | 69.89M | -2.07% | 72,124 | 920.48K |
| 391 | CGTX | Cognition Therapeutics, Inc. | 69.40M | -0.38% | 420,602 | - |
| 392 | HRTX | Heron Therapeutics, Inc. | 68.54M | -4.12% | 1,725,606 | 151.18M |
| 393 | NTHI | NeOnc Technologies Holdings, Inc. | 67.11M | -1.82% | 104,009 | 39.99K |
| 394 | MAIA | MAIA Biotechnology, Inc. | 66.91M | -1.79% | 362,854 | - |
| 395 | CSBR | Champions Oncology, Inc. | 65.42M | -1.88% | 1,790 | 60.66M |
| 396 | XBIT | XBiotech Inc. | 64.63M | -1.85% | 68,197 | - |
| 397 | SPRO | Spero Therapeutics, Inc. | 64.06M | -2.65% | 361,227 | 47.00M |
| 398 | ONCY | Oncolytics Biotech Inc. | 63.51M | -9.04% | 1,334,060 | - |
| 399 | CING | Cingulate Inc. | 63.40M | -0.91% | 228,559 | - |
| 400 | BMEA | Biomea Fusion, Inc. | 62.98M | 3.89% | 3,782,874 | - |
| 401 | FBIO | Fortress Biotech, Inc. | 62.37M | -2.09% | 264,282 | 68.47M |
| 402 | VRCA | Verrica Pharmaceuticals Inc. | 61.76M | -4.89% | 116,473 | 30.32M |
| 403 | HYFT | MindWalk Holdings Corp. | 61.72M | -6.43% | 239,627 | 11.57M |
| 404 | OSTX | OS Therapies Incorporated | 60.89M | -6.38% | 527,873 | - |
| 405 | CNTB | Connect Biopharma Holdings Limited | 57.07M | 0.01% | 548,341 | 2.95M |
| 406 | ALPS | Alps Group Inc | 56.58M | 0.29% | 23,412 | 3.74M |
| 407 | XLO | Xilio Therapeutics, Inc. | 56.26M | -5.21% | 29,597 | 64.09M |
| 408 | PLRX | Pliant Therapeutics, Inc. | 55.72M | -7.46% | 582,309 | - |
| 409 | GANX | Gain Therapeutics, Inc. | 54.99M | -5.26% | 464,369 | - |
| 410 | GOSS | Gossamer Bio, Inc. | 53.64M | -1.35% | 171,012 | 53.29M |
| 411 | BOLD | Boundless Bio, Inc. | 53.00M | -0.85% | 711,179 | - |
| 412 | ELOX | Eloxx Pharmaceuticals, Inc. | 52.72M | -4.67% | 66,491 | - |
| 413 | RNXT | RenovoRx, Inc. | 51.45M | -4.20% | 271,826 | 1.98M |
| 414 | RNTX | Rein Therapeutics Inc. | 50.92M | -6.00% | 363,645 | - |
| 415 | CRBU | Caribou Biosciences, Inc. | 50.38M | 1.12% | 2,940,787 | 10.04M |
| 416 | MREO | Mereo BioPharma Group plc | 49.30M | -0.13% | 720,541 | 500.00K |
| 417 | IBIO | iBio, Inc. | 49.28M | -2.11% | 309,248 | 100.00K |
| 418 | ACET | Adicet Bio, Inc. | 49.19M | -11.09% | 188,437 | - |
| 419 | LONA | LeonaBio, Inc. | 48.99M | -1.70% | 61,313 | - |
| 420 | INKT | MiNK Therapeutics, Inc. | 48.02M | -5.33% | 13,609 | - |
| 421 | HOWL | Werewolf Therapeutics, Inc. | 47.63M | -1.71% | 309,202 | 21.00M |
| 422 | KLRS | Kalaris Therapeutics, Inc. | 47.61M | -8.68% | 58,312 | - |
| 423 | ATHE | Alterity Therapeutics Limited | 47.33M | -3.68% | 55,910 | 2.50M |
| 424 | APLM | Apollomics, Inc. | 46.34M | 0.48% | 6,231 | 8.84M |
| 425 | IMA | ImageneBio, Inc. | 45.52M | -0.50% | 9,643 | 800.00K |
| 426 | HYPD | Hyperion DeFi, Inc. | 44.13M | -9.84% | 243,046 | 1.40M |
| 427 | CLNN | Clene Inc. | 44.06M | -6.20% | 200,197 | 197.00K |
| 428 | SER | Serina Therapeutics, Inc. | 43.69M | -3.91% | 14,655 | 130.00K |
| 429 | INMB | INmune Bio Inc. | 43.57M | -4.85% | 196,168 | 50.00K |
| 430 | ANVS | Annovis Bio, Inc. | 42.32M | -5.39% | 641,421 | - |
| 431 | ALDX | Aldeyra Therapeutics, Inc. | 42.23M | -5.05% | 1,808,399 | - |
| 432 | DWTX | Dogwood Therapeutics, Inc. | 41.47M | -2.40% | 69,823 | - |
| 433 | ELTX | Elicio Therapeutics, Inc. | 41.00M | -12.36% | 333,436 | - |
| 434 | CELU | Celularity Inc. | 40.56M | -6.02% | 63,435 | 18.97M |
| 435 | TIL | Instil Bio, Inc. | 40.08M | -3.59% | 25,171 | - |
| 436 | GRCE | Grace Therapeutics, Inc. | 39.34M | -4.10% | 168,652 | - |
| 437 | VERU | Veru Inc. | 39.22M | -5.74% | 301,081 | 16.89M |
| 438 | BSEM | BioStem Technologies, Inc. | 38.84M | 2.45% | 33,305 | 34.59M |
| 439 | EXOZ | eXoZymes, Inc. | 37.96M | 2.25% | 31,792 | -700.00 |
| 440 | ATNM | Actinium Pharmaceuticals, Inc. | 35.53M | 6.60% | 174,290 | 35.09M |
| 441 | NNVC | NanoViricides, Inc. | 35.22M | 0.73% | 154,846 | - |
| 442 | LITS | Lite Strategy, Inc. | 34.97M | -3.77% | 115,675 | - |
| 443 | EDSA | Edesa Biotech, Inc. | 34.72M | -3.75% | 63,809 | - |
| 444 | FLNA | Filana Therapeutics, Inc. | 33.98M | -7.53% | 327,927 | - |
| 445 | CRVO | CervoMed Inc. | 33.87M | -0.44% | 98,423 | 331.30K |
| 446 | IRLA | IRulya Therapeutics Inc. | 32.58M | -3.61% | 11,511 | - |
| 447 | CVM | CEL-SCI Corporation | 31.48M | 2.87% | 168,167 | - |
| 448 | ALGS | Aligos Therapeutics, Inc. | 30.79M | -8.53% | 67,479 | 31.52M |
| 449 | GRDX | GridAI Technologies Corp. | 29.88M | -5.38% | 113,159 | - |
| 450 | BCTX | BriaCell Therapeutics Corp. | 29.66M | -9.69% | 131,459 | - |
| 451 | MGX | Metagenomi Therapeutics, Inc. | 29.62M | -7.24% | 163,235 | 13.56M |
| 452 | ATOS | Atossa Therapeutics, Inc. | 29.04M | 9.81% | 102,802 | - |
| 453 | NXTC | NextCure, Inc. | 29.02M | -7.85% | 39,000 | - |
| 454 | RNAZ | TransCode Therapeutics, Inc. | 28.78M | -5.56% | 28,865 | - |
| 455 | IGC | IGC Pharma, Inc. | 25.43M | -3.19% | 404,471 | 1.11M |
| 456 | MCRB | Seres Therapeutics, Inc. | 24.71M | -2.77% | 37,945 | 1.88M |
| 457 | PLRZ | Polyrizon Ltd. | 24.29M | -0.10% | 19,355 | - |
| 458 | ABVC | ABVC BioPharma, Inc. | 23.80M | -1.57% | 29,194 | 797.92K |
| 459 | EVAX | Evaxion A/S | 23.60M | 1.07% | 74,131 | 7.49M |
| 460 | IMMP | Immutep Limited | 23.38M | -0.31% | 11,842 | 13.79M |
| 461 | BYSI | BeyondSpring Inc. | 22.99M | -3.90% | 11,848 | 1.88M |
| 462 | IBO | Impact BioMedical Inc. | 22.90M | -15.15% | 10,194 | 35.00K |
| 463 | CNTX | Context Therapeutics Inc. | 22.42M | 1.46% | 2,235,658 | - |
| 464 | GUTS | Fractyl Health, Inc. | 20.56M | -62.74% | 14,891,453 | 3.00K |
| 465 | QNTM | Quantum BioPharma Ltd. | 19.98M | -8.86% | 190,321 | - |
| 466 | COCP | Cocrystal Pharma, Inc. | 19.65M | -0.97% | 22,775 | 330.00K |
| 467 | KYNB | Kyntra Bio, Inc. | 19.64M | -9.51% | 28,756 | 4.62M |
| 468 | QNRX | Quoin Pharmaceuticals, Ltd. | 18.74M | -3.23% | 31,568 | - |
| 469 | ESLA | Estrella Immunopharma, Inc. | 18.70M | -19.66% | 4,232,553 | - |
| 470 | AKTX | Akari Therapeutics, Plc | 18.69M | -7.47% | 21,683 | - |
| 471 | NEUP | Neuphoria Therapeutics Inc. | 17.86M | -0.30% | 72,661 | 1.17M |
| 472 | MRKR | Marker Therapeutics, Inc. | 17.34M | 13.04% | 1,125,189 | 3.55M |
| 473 | ATYR | aTyr Pharma, Inc. | 17.07M | -5.33% | 1,801,635 | 190.00K |
| 474 | PBM | Psyence Biomedical Ltd. | 16.10M | -2.31% | 26,499 | - |
| 475 | JSPR | Jasper Therapeutics, Inc. | 15.97M | -9.81% | 245,631 | - |
| 476 | TCRX | TScan Therapeutics, Inc. | 15.66M | -3.47% | 568,221 | 7.11M |
| 477 | KPRX | Kiora Pharmaceuticals, Inc. | 15.27M | -0.41% | 11,883 | 20.00K |
| 478 | ICU | SeaStar Medical Holding Corporation | 15.26M | -5.23% | 140,462 | 1.71M |
| 479 | DYAI | Dyadic International, Inc. | 14.98M | -1.98% | 77,490 | 3.80M |
| 480 | ACTU | Actuate Therapeutics, Inc. | 14.53M | 21.02% | 884,732 | - |
| 481 | NCEL | NewcelX Ltd. | 14.44M | -12.28% | 23,099 | - |
| 482 | DARE | Daré Bioscience, Inc. | 14.25M | -2.08% | 77,207 | 1.37M |
| 483 | ALLR | Allarity Therapeutics, Inc. | 14.24M | 7.48% | 215,711 | 345.00K |
| 484 | KTTA | Pasithea Therapeutics Corp. | 14.23M | 3.83% | 209,310 | - |
| 485 | BCDA | BioCardia, Inc. | 13.93M | -1.96% | 104,751 | 3.00K |
| 486 | TVRD | Tvardi Therapeutics, Inc. | 13.47M | -5.61% | 91,719 | - |
| 487 | HIND | Vyome Holdings, Inc. | 13.12M | -2.09% | 11,235 | 129.73K |
| 488 | CNSY | Cerenome, Inc. | 12.90M | -9.57% | 84,939 | 4.20M |
| 489 | LPCN | Lipocine Inc. | 12.86M | -7.14% | 394,836 | 1.57M |
| 490 | GTBP | GT Biopharma, Inc. | 12.68M | -4.48% | 55,229 | - |
| 491 | CTXR | Citius Pharmaceuticals, Inc. | 12.63M | - | 139,507 | 7.11M |
| 492 | AEON | AEON Biopharma, Inc. | 11.57M | -4.53% | 240,480 | - |
| 493 | PLUR | Pluri Inc. | 11.48M | -1.07% | 9,118 | 1.02M |
| 494 | RADX | Radiopharm Theranostics Limited | 11.45M | -4.63% | 106,391 | 8.90M |
| 495 | PASG | Passage Bio, Inc. | 11.26M | -2.78% | 16,688 | - |
| 496 | INTS | Intensity Therapeutics, Inc. | 10.97M | -0.59% | 32,310 | - |
| 497 | INAB | IN8bio, Inc. | 10.94M | -6.33% | 30,462 | - |
| 498 | CLRB | Cellectar Biosciences, Inc. | 10.78M | -4.20% | 335,816 | - |
| 499 | GDTC | CytoMed Therapeutics Limited | 10.50M | 1.14% | 7,222 | 609.73K |
| 500 | BLRX | BioLineRx Ltd. | 10.38M | -1.95% | 12,580 | 1.39M |